Visit WTR Logo
Subscribe now
PanOptis acquired by New York-based private equity business

The NPE, which bought Unwired Planet in 2016 and owns thousands of patents previously held by Ericsson and Panasonic, sold to Brevet Capital for an undisclosed sum

PanOptis acquired by New York-based private equity business
15 Feb 2019

AbbVie’s Humira strategy to be scrutinised in first evergreening unclean hands challenge

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug.

15 Feb 2019

Takeover wars intensify between listed IP firms in Australia

Aggressive move by the country’s largest public IP services group seems designed to thwart the merger of two smaller rivals. But further consolidation in the space still looks likely

Featured

14 Feb
2019

As 101 debate continues, Iancu offers clear message to Federal Circuit

With new guidelines set to reshape patent examination, the USPTO head makes the case for revisiting subject matter precedent Read more

14 Feb
2019

World’s most valuable startup buys patents again

The company behind Tik Tok bought out much of a struggling smartphone maker’s patent portfolio in January. USPTO assignments from last week show what assets Beijing-based ByteDance came away with Read more

13 Feb
2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco  Read more

Most reads

1

How patents are shaping up for virtual and augmented reality

2

The big life sciences patent developments in January

3

Bridgestone's TomTom acquisition shows that data is the new gold rush

4

US patent system jumps to second in the world, though the biopharma sector may not agree

5

IBM set to join LOTNet; CAFC decision good news for pharma; TiVo could split; the US’s first biosimilar’s case; and plenty more

News

View all
14 Feb 2019

The five key takeaways from the USPTO’s report on women and patents

Although female patentees are becoming more common – particularly in areas such as pharma and biotech – the rate of growth is slowing, suggesting that a lot more work needs to be done before equality between the sexes is achieved Read more

11 Feb 2019

Huawei owns the future and that’s why it’s here to stay

Deep pockets, a strong commitment to R&D and a world class 5G patent portfolio mean that whatever its current difficulties the Chinese telecoms business is set to be a major player for the long term Read more

10 Feb 2019

IBM set to join LOTNet; CAFC decision good news for pharma; TiVo could split; the US’s first biosimilar’s case; and plenty more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one Read more

9 Feb 2019

The big life sciences patent developments in January

Record-breaking Celgene purchase, two decisions on the on-sale bar, Europe moves towards SPC manufacturing waiver, China proposes five-year patent term extension and much more Read more

Analysis

View all
12 Feb 2019

New investment platform aims to break down barriers to capital for innovators

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative Read more

12 Feb 2019

AT&T’s portfolio is a treasure trove for buyers

The telecoms giant is building its presence in the secondary market with a host of companies now seeking out its high-quality patents   Read more

12 Feb 2019

China’s domestic licensing market has plenty of room to grow

An annual survey conducted by CNIPA pegs the licensing rate of Chinese patents at 5.5%. That's not far off estimates of US patent utilisation Read more

11 Feb 2019

Apple’s courtroom strategy shows team monetising former portfolio of Blackberry patents faces biggest licensing challenge

The iPhone maker moves for declaratory judgment claiming non infringement of grants relating to charging technology Read more

Events

View all
27-28 March
2019
Latest

IPBC Europe 2019

In the era of the fourth industrial revolution (4IR), European companies are faced with a number of exciting opportunities – but also significant IP challenges. Designed by and for European IP owners, the programme for IPBC Europe 2019 will explore how IP managers inside the continent’s businesses can devise and build sustainable value creation programmes in the rapidly changing world.

16-18 June
2019
Latest

IPBC Global 2019

The leading gathering of global IP decision makers and thought-leaders returns to Boston! As the fourth industrial revolution gathers pace, IPBC Global’s 2019 programme explores the key IP issues this new era of change and innovation presents for corporate leaders, policy makers, investors, the legal profession and third-party service providers.

Insights

30 Jan 2019

IP market news highlights

The big stories from the IAM platform in December and January. Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

IP market news highlights

Some of the major stories carried on the IAM platform in October and November. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

Analysis

Latest analysis reports from IAM.

Thought leadership

IAM offers an extensive range of special reports.

Why subscribe?

Our unique and timely intelligence service informs commercial trademark decision making in boardrooms globally by translating trademark law into business sense.

Subscribe now
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.